ATRA vs GILD: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Gilead Sciences Inc in 2026
ATRA
Atara Biotherapeutics Inc
$4.32
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ATRA | GILD | Winner |
|---|---|---|---|
| Market Cap | $32.73M | $154.03B | GILD |
| P/E Ratio | 1.59 | 19.22 | ATRA |
| EPS (TTM) | $2.86 | $6.46 | GILD |
| Revenue Growth | -0.9% | 0.0% | GILD |
| Gross Margin | 46.8% | 78.7% | GILD |
Analyze ATRA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or GILD a better investment?
Comparing ATRA and GILD: Atara Biotherapeutics Inc has a market cap of $32.73M while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and GILD?
ATRA (Atara Biotherapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or GILD?
Based on P/E ratios, ATRA trades at a lower multiple (1.6x vs 19.2x).
Which is growing faster: ATRA or GILD?
GILD has higher revenue growth at 0.0% vs -0.9% for ATRA.
Which company is more profitable: ATRA or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 46.8% for ATRA.
Which is the larger company: ATRA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $32.73M for ATRA.
Should I buy ATRA or GILD in 2026?
Both ATRA and GILD have investment merit. ATRA trades at $4.32 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and GILD stock?
Key differences: Market Cap ($32.73M vs $154.03B), P/E Ratio (1.6x vs 19.2x), Revenue Growth (-0.9% vs 0.0%), Gross Margin (46.8% vs 78.7%).